Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Modified GRF 1-29 is the more technically accurate name for the same peptide
Some inflammation is necessary for healing, but excessive inflammation impairs recovery
In comparison, prescription GLP-1 weight-loss drugs lead people to lose 15-20% of their body weight
The compound is neither approved nor intended for therapeutic, diagnostic, or any consumer-facing purpose
Genomic analysis using the Broad Institutes Connectivity Map showed that GHK-Cu can influence the expression of numerous human genes
Saxenda (liraglutide 3.0 mg) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, alongside diet and exercise
US$ 22.36
US$ 28.08
US$ 20.40
US$ 28.76
US$ 24.36
